Ignite Creation Date:
2024-05-06 @ 2:27 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04328350
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2020-03-27
Brief Title:
Social Experiences of Adolescents and Young Adults With Cancer
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Study Overview
Official Title:
Social Experiences of Adolescents and Young Adults With Cancer
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Participants are being asked to take part in this clinical trial a type of research study because investigators want to learn more about the social experiences adolescents and young adults who are being treated or have been treated for cancer
Primary Objectives
Describe differences in social experience variables peer connectedness perceived social competence parent versus peer attachment based on treatment status on versus off therapy
In on-therapy patients describe differences in social experience variables peer connectedness perceived social competence parent versus peer attachment based on developmental stage high school versus post-high school
Secondary Objectives
Assess the social support and peer interaction needs of AYA with cancer as a means of determining stakeholder interest and need for psychosocial interventions targeting social experiences
Using qualitative interviews explore patient perceptions of the impact of cancer on social experiences among AYA particularly with regards to changes in friendships as a result of the cancer diagnosis and the role of the hospital in helping or hindering friendship maintenancedevelopment
Exploratory Objectives
Explore differences in social experience by demographic disease and treatment factors including gender diagnostic category brain tumor leukemialymphoma solid tumor late effectssymptom burden and treatment eg treatment intensity serious medical events
Explore associations between perceived impact of cancer and social experience in AYA
Explore associations between use of social media and social experience
Explore associations between social experiences and overall functioning quality of life distress coping
Explore the possibility of subclasses of AYA by using person-centered analyses to empirically derive profiles of social experience
Primary Objectives
Describe differences in social experience variables peer connectedness perceived social competence parent versus peer attachment based on treatment status on versus off therapy
In on-therapy patients describe differences in social experience variables peer connectedness perceived social competence parent versus peer attachment based on developmental stage high school versus post-high school
Secondary Objectives
Assess the social support and peer interaction needs of AYA with cancer as a means of determining stakeholder interest and need for psychosocial interventions targeting social experiences
Using qualitative interviews explore patient perceptions of the impact of cancer on social experiences among AYA particularly with regards to changes in friendships as a result of the cancer diagnosis and the role of the hospital in helping or hindering friendship maintenancedevelopment
Exploratory Objectives
Explore differences in social experience by demographic disease and treatment factors including gender diagnostic category brain tumor leukemialymphoma solid tumor late effectssymptom burden and treatment eg treatment intensity serious medical events
Explore associations between perceived impact of cancer and social experience in AYA
Explore associations between use of social media and social experience
Explore associations between social experiences and overall functioning quality of life distress coping
Explore the possibility of subclasses of AYA by using person-centered analyses to empirically derive profiles of social experience
Detailed Description:
A mixed-methods design involving questionnaires and interviews will be used to evaluate the study objectives AYA ages 15 to 22 will be recruited to participate Two cohorts will be enrolled AYA who are on-treatment 2-12 months post-diagnosis and AYA who are off-therapy 1 to 4 years AYA will complete questionnaires assessing peer versus family connectedness peerromantic competence coping distress social support and quality of life A study-specific needs assessment regarding interest in social functioning interventions will also be completed If a caregiver is available they will be asked to complete questionnaires regarding family functioning and quality of life A subset of 50 AYA 30 on-therapy20 off-therapy will be interviewed to further explore aspects of peerfamily connectedness and intervention interest Analyses will focus on describing how aspects of social experiences peer connectedness social competence peer versus parent attachment differ based on treatment status on versus off therapy and developmental stage high school versus post-high school as well as potential moderators
Two cohorts of AYA with cancer ages 15-22 will be identified and recruited for the study 1 patients on-therapy 2-12 months from diagnosis and 2 patients off- therapy 1-4 years and 13 years of age at diagnosis AYA from all diagnostic groups - brain tumor solid tumor leukemialymphoma - and developmental periods - high school post-high school - will be targeted and care will be taken to ensure a representative sample
Two cohorts of AYA with cancer ages 15-22 will be identified and recruited for the study 1 patients on-therapy 2-12 months from diagnosis and 2 patients off- therapy 1-4 years and 13 years of age at diagnosis AYA from all diagnostic groups - brain tumor solid tumor leukemialymphoma - and developmental periods - high school post-high school - will be targeted and care will be taken to ensure a representative sample
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None